Modeling and predicting the long-term effects of various strategies and objectives of varicella-zoster vaccination campaigns

References

• Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press; 1991.
   Google Scholar
• Newall AT, Dehollain JP, Wood JG. Under-explored assumptions in influenza vaccination models: implications for the universal vaccination of children. Vaccine. 2012;30:5776–5781.
   PubMed Web of Science ®Google Scholar
• Buonomo B. A simple analysis of vaccination strategies for rubella. Math Biosci Eng. 2011;8:677–687.
   PubMed Web of Science ®Google Scholar
• Huang S-Z. A new SEIR epidemic model with applications to the theory of eradication and control of diseases, and to the calculation of R0. Math Biosci. 2008;215:84–104.
   PubMed Web of Science ®Google Scholar
• Chen SC, Chang CF, Jou LJ, et al. Modelling vaccination programmes against measles in Taiwan. Epidemiol Infect. 2007;135:775–786.
   PubMed Web of Science ®Google Scholar
• Halloran ME, Haber MJ, Longini IM, et al. Direct and indirect effects in vaccine efficacy and effectiveness. Am J Epidemiol. 1991;133:323–331.
   PubMed Web of Science ®Google Scholar
• Matrajt L Jr., Longini IM. Optimizing vaccine allocation at different points in time during an epidemic. PLoS One. 2010;5:e13767.
   PubMed Web of Science ®Google Scholar
• Brisson M, Melkonyan G, Drolet M, et al. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster. Vaccine. 2010;28:3385–3397.
   PubMed Web of Science ®Google Scholar
• Andrei G, Snoeck R. Advances in the treatment of varicella-zoster virus infections. Adv Pharmacol. 2013;67:107–168.
   PubMedGoogle Scholar
• Oxman MN. Zoster vaccine: current status and future prospects. Clin Infect Dis. 2010;51:197–213.
   PubMed Web of Science ®Google Scholar
• Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet. 2002;360:678–682.
   PubMed Web of Science ®Google Scholar
• Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9–20.
   PubMedGoogle Scholar
• Reynolds MA, Chaves SS, Harpaz R, et al. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. J Infect Dis. 2008;197:S224–S227.
   PubMed Web of Science ®Google Scholar
• Oxman MN. (Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology. 1995;45:S41–S46.
   PubMed Web of Science ®Google Scholar
• Gao Z, Wood JG, Gidding HF, et al. Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future. Epidemiol Infect. 2015;143:1467–1476.
   PubMed Web of Science ®Google Scholar
• Lian I-B, Chien Y-Z, Hsu P-S, et al. The changing epidemiology of varicella incidence after implementation of the one-dose varicella vaccination policy. Vaccine. 2011;29:1448–1454.
   PubMed Web of Science ®Google Scholar
• Poletti P, Melegaro A, Ajelli M, et al. Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries. PLoS One. 2013;8:e60732.
   PubMed Web of Science ®Google Scholar
• Drolet M, Oxman MN, Levin MJ, et al. Vaccination against herpes zoster in developed countries: state of the evidence. Hum Vaccin Immunother. 2013;9:1177–1184.
   PubMed Web of Science ®Google Scholar
• van Hoek AJ, Melegaro A, Zagheni E, et al. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine. 2011;29:2411–2420.
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ, Gay NJ, et al. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000;125:651–669.
   PubMed Web of Science ®Google Scholar
• Gao Z, Gidding HF, Wood JG, et al. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia. Epidemiol Infect. 2010;138:457–468.
   PubMed Web of Science ®Google Scholar
• van Hoek AJ, Gay N, Melegaro A, et al. Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales. Vaccine. 2009;27:1454–1467.
   PubMed Web of Science ®Google Scholar
• Keeling MJ, Rohani P. Modeling infectious diseases in humans and animals. Princeton: Princeton University Press; 2007.
   Google Scholar
• Bonmarin I, Santa-Olalla P, Lévy-Bruhl D. Modeling the impact of vaccination on the epidemiology of varicella zoster virus. Rev Epidemiol Sante Publique. 2008;56:323–331.
   PubMed Web of Science ®Google Scholar
• Karhunen M, Leino T, Salo H, et al. Modelling the impact of varicella vaccination on varicella and zoster. Epidemiol Infect. 2010;38:469–481.
   Web of Science ®Google Scholar
• de Vries R, Kretzschmar M, Schellekens JF, et al. Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model. PLoS One. 2010;5:e13392.
   PubMed Web of Science ®Google Scholar
• Coudeville L, van Rie A, André P. Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies. Epidemiol Infect. 2008;136:604–620.
   PubMed Web of Science ®Google Scholar
• Robertson S. Immunological basis for immunization series. Module 8: yellow fever. Global programme for vaccines and immunization – expanded programme on immunization. Geneva: World Health Organization; 1993.
   Google Scholar
• Melegaro A, Choi YH, George R, et al. Dynamic models of pneumococcal carriage and the impact of the heptavalent pneumococcal conjugate vaccine on invasive pneumococcal disease. BMC Infect Dis. 2010;10:90.
   PubMed Web of Science ®Google Scholar
• Edmunds WJ, van de Heijden OG, Eerola M, et al. Modelling rubella in Europe. Epidemiol Infect. 2000;125:617–634.
   PubMed Web of Science ®Google Scholar
• Gilden D. Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia. J Intern Med. 2011;269:496–506.
   PubMed Web of Science ®Google Scholar
• Sanford M, Keating GM. Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults. Drugs Aging. 2010;27:159–176.
   PubMed Web of Science ®Google Scholar
• Levin MJ, Gershon AA, Dworkin RH, et al. Prevention strategies for herpes zoster and post-herpetic neuralgia. J Clin Virol. 2010;48 Suppl 1:S14–S19.
   PubMed Web of Science ®Google Scholar
• Baxter R, Tran TN, Ray P, et al. Impact of vaccination on the epidemiology of varicella: 1995–2009. Pediatrics. 2014;134:24–30
   Google Scholar